Nintedanib | compare suppliers & send inquiries for free
Looking for Nintedanib 656247-17-5?
Why are people looking for Nintedanib? Nintedanib is a small molecule kinase inhibitor used in the treatment of pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease, and non-small cell lung cancer (NSCLC) It was first approved for use in the United States in 2014. Within the spectrum of idiopathic pulmonary fibrosis treatment options, nintedanib is currently one of only two disease-modifying therapies available and indicated for the condition (the other being Pirfenidone) and as such is used as a first-line treatment following diagnosis to slow down the progressive loss of lung function. As a chemotherapeutic agent for NSCLC, nintedanib, in combination with Docetaxel, is reserved for patients who have tried and failed first-line chemotherapeutic options.
Do you want to buy this product? Send an inquiry to the listed suppliers that meets your quality requirements.
Nintedanib manufacturers | traders | suppliers
We have 8 companies offering Nintedanib from 4 different countries.
Get in contact with the supplier of your choice:
- MSN Labs. from India
- JINLAN Pharm-Drugs Technology Co., Ltd. from China
- Sun Pharma from India
- Suzhou Bichal Biological Technology from China
- Olon from Italy
- Glenmark Pharma from India
- Formosa Labs from Taiwan
- Cipla from India
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.